NCT03485144View on ClinicalTrials.gov

A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

December 12, 2017

Primary Completion Date

May 10, 2019

Study Completion Date

May 10, 2019

Conditions
Dengue
Interventions
BIOLOGICAL

TV003

Live attenuated virus vaccine-TetraVax-DV

BIOLOGICAL

Placebo for TV003

Placebo

Trial Locations (1)

Unknown

National Taiwan University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Medigen Vaccine Biologics Corp.

INDUSTRY

NCT03485144 - A Clinical Study to Evaluate TV003 in Healthy Adults in Taiwan | Biotech Hunter | Biotech Hunter